Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
STAT+ Conversations
STAT+

Eli Lilly’s Dan Skovronsky on Covid-19, Alzheimer’s, and the place of entrepreneurs in pharma

  • Matthew Herper

By Matthew Herper July 7, 2020

Reprints

Editor’s note: A recording of this conversation is embedded below. 

Eli Lilly was the first company to enter clinical trials with a drug designed to treat Covid-19. The medicine, a monoclonal antibody, will be tested for both treating and preventing infection in patients who have been exposed to the disease.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Matthew Herper

Matthew Herper

Senior Writer, Medicine, Editorial Director of Events

Matthew Herper covers medical innovation — both its promise and its perils.

Tags

Newly available test strips can detect lethal ‘tranq’ in…
Newly available test strips can detect lethal ‘tranq’ in drug supply
Wary of changes to Medicare Advantage, health insurers put…
Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the…
Experts weigh in on potential health hazards posed by…
Experts weigh in on potential health hazards posed by chemicals in Ohio train derailment
Oscar Health names former Aetna executive as new CEO
Oscar Health names former Aetna executive as new CEO
Pharmalittle: Ohio attorney general accuses PBMs of price fixing;…
Pharmalittle: Ohio attorney general accuses PBMs of price fixing; how cost-effectiveness fight could hobble drug price…
With new study data, Intra-Cellular could expand use of…
With new study data, Intra-Cellular could expand use of approved mood-disorder treatment

Recommended Stories